Shares of BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) rose 3.6% during mid-day trading on Friday . The company traded as high as $0.17 and last traded at $0.17. Approximately 10,000 shares were traded during mid-day trading, an increase of 237% from the average daily volume of 2,963 shares. The stock had previously closed at $0.16.
BioNxt Solutions Trading Up 3.6 %
The business’s fifty day moving average price is $0.18 and its 200 day moving average price is $0.21.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The company reported ($0.01) EPS for the quarter.
BioNxt Solutions Company Profile
BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.
Featured Articles
- Five stocks we like better than BioNxt Solutions
- What Are Dividend Contenders? Investing in Dividend Contenders
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Time to Load Up on Home Builders?
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
